Providence stroke experts weigh in on the impact of recent research that will dramatically increase providers' ability to treat acute stroke:
The word "breakthrough" gets tossed around a lot in health news. But this update on stroke treament might just deserve such a big adjective. Dr. Ted Lowenkopf, medical director for the Providence Stroke Center, describes it as "practice-changing" in his recent article reviewing the results of the DAWN and DEFUSE 3 stroke trials. And Dr. Amit Kansara, associate medical director for Providence Telestroke, says in his interviews with KGW 8 and KATU news that this advancement could more than double the number of patients eligible for life-saving stroke treatment.
